4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Bright Minds Biosciences Inc. (DRUG) operates in the Biotechnology industry and is headquartered in New York, United States with about 26 employees. Its market capitalization is roughly $700 million. In the fiscal year ended 2025-09-30, DRUG reported $0M in revenue and ($12M) in net income.
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.
Interactive charts & full statements →
| Income statement | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($14M) | ($3M) | ($7M) | ($15M) | — |
| Net Income | ($12M) | ($3M) | ($7M) | ($15M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($15M) | ($7M) | ($6M) | ($3M) | ($3M) | — |
| Net Income | ($10M) | ($8M) | ($4M) | ($5M) | ($3M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Assets | $84M | $6M | $7M | $12M | — |
| Total Liabilities | $2M | $1M | $0M | $2M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DRUG viewer.
About TickerBase · Data methodology & sources